E-LIB Suche - Ergebnisse für: Ferreri, A.J.M.

1

Primary central nervous system lymphomas: EHA–ESMO Clinical..:

Ferreri, A.J.M. ; Illerhaus, G. ; Doorduijn, J.K....
Annals of Oncology. 35 (2024) 6 - p. 491-507 , 2024

Link: https://doi.org/10.1016/..

2

Radioimmunotherapy versus autologous hematopoietic stem cel..:

Ladetto, M. ; Tavarozzi, R. ; Zanni, M....
Annals of Oncology. 35 (2024) 1 - p. 118-129 , 2024

Link: https://doi.org/10.1016/..

3

THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTAC..:

Ferreri, A. J. M. ; Sassone, M. C. ; Cangi, M. G....
Hematological Oncology. 41 (2023) S2 - p. 106-107 , 2023

Link: https://doi.org/10.1002/..

4

A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PR..:

Davies, A. J. ; Zucca, E. ; Ceriani, L....
Hematological Oncology. 41 (2023) S2 - p. 48-50 , 2023

Link: https://doi.org/10.1002/..

5

Toward a feminist housing commons? Conceptualising care - (..:

Fernández Arrigoitia, Melissa ; Ferreri, M. ; Hudson, J...
Housing, Theory and Society. 40 (2023) 5 - p. 660-678 , 2023

Link: https://doi.org/10.1080/..

6

P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WI..:

Chiattone, C. ; Civallero, M. ; Fischer, T....
HemaSphere. 6 (2022) - p. 1094-1095 , 2022

Link: https://doi.org/10.1097/..

7

P1239: TISLELIZUMAB, A PD-1 INHIBITOR FOR RELAPSED/REFRACTO..:

Bachy, E. ; Savage, K. J. ; Huang, H....
HemaSphere. 6 (2022) - p. 1124-1125 , 2022

Link: https://doi.org/10.1097/..

8

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLEC..:

Fowler, N. H. ; Dickinson, M. ; Martinez‐Lopez, J....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

9

SARS‐COV‐2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHO..:

Ferreri, A. J. M. ; Steffanoni, S. ; Calimeri, T....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PR..:

Martelli, M. ; Zucca, E. ; Botto, B....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

11

How we treat primary central nervous system lymphoma:

Calimeri, T. ; Steffanoni, S. ; Gagliardi, F...
ESMO Open. 6 (2021) 4 - p. 100213 , 2021

Link: https://doi.org/10.1016/..

12

Erratum to 'How we treat primary central nervous system lym..:

Calimeri, T. ; Steffanoni, S. ; Gagliardi, F...
ESMO Open. 6 (2021) 6 - p. 100326 , 2021

Link: https://doi.org/10.1016/..

13

Quantitative muscle mass biomarkers are independent prognos..:

Leone, R. ; Sferruzza, G. ; Calimeri, T....
European Journal of Radiology. 143 (2021) - p. 109945 , 2021

Link: https://doi.org/10.1016/..

14

SAFETY AND EFFICACY OF THE "CARMEN" REGIMEN, A NEW DOSE‐DEN..:

Ferreri, A. J. M ; Angelillo, P ; Erbella, F...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

15

PROGNOSTIC FACTORS, MANAGEMENT AND OUTCOME OF AN INTERNATIO..:

Ferreri, A. J.M. ; Tarantino, V. ; Cabras, G....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..